Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency

Published:2019-12-18 Issue:1 Volume:25 Page:17-25
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Gorkom Britta Laros-van¹,Holme Pål André²,Joch Christine³,Rogosch Tobias³^ORCID,Feussner Annette³,McKeand William⁴,Roberts John⁴,van Heerde Waander¹⁵⁶

Affiliation:

1. Department of Hematology and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway

3. CSL Behring, Marburg, Germany

4. CSL Behring, King of Prussia, USA

5. Department of Laboratory Medicine, Hematology Laboratory, Radboud University Medical Center, Nijmegen, Netherlands

6. Enzyre, Novio Tech Campus, Nijmegen, The Netherlands

Funder

CSL Behring

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link